BHVN Q2 2025 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$212M

Net Income

-$198M

EPS (Diluted)

$-1.94

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$168M

Free Cash Flow

-$168M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$550M

Total Liabilities

$416M

Stockholders' Equity

$135M

Cash & Equivalents

$166M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$212M	-$334M	+36.6%
Net Income	-$198M	-$320M	+38.0%